Laura Brege

ACAD

Laura Brege serves as Director at ACADIA Pharmaceuticals Inc. (ACAD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$654.7K

Net Position

Net Seller

$654.7K

Companies Traded

ACAD

Active Period

Jan 2023 – Jun 2025

3 total trades

Most Recent

Sell ACAD

Jun 4, 2025 · $314.6K

Laura Brege's Insider Trading at ACADIA Pharmaceuticals Inc. (ACAD)

Buys

0 · $0.00

Sells

3 · $654.7K

Total Shares Bought

Total Shares Sold

31,446

ACAD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 4, 2025↗	Sell	14,446	$21.78	$314.6K	0
Jun 14, 2023↗	Sell	4,500	$24.87	$111.9K	13,502
Jan 17, 2023↗	Sell	12,500	$18.25	$228.1K	0

Related Insiders

Jennifer J Rhodes

EVP, CHIEF LEGAL OFFICER, SEC

ACADSell · Feb 9, 2026

Jennifer J Rhodes

officer: EVP, CHIEF LEGAL OFFICER, SEC

ACADSell · Feb 9, 2026

James Kihara

PRINCIPAL ACCOUNTING OFFICER

ACADSell · Nov 18, 2025

Mark C. Schneyer

EVP, CHIEF FINANCIAL OFFICER

ACADSell · Nov 18, 2025

James M Daly

Director

ACADSell · Nov 10, 2025

GAROFALO ELIZABETH A.

Director

ACADSell · Sep 2, 2025

Explore More Insider Trading Data

ACAD Insider Trading Activity

View all insider trades at ACADIA Pharmaceuticals Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity